The increase in cancer incidence was MLH1: 7.76% vs. 3.84% and MSH6: 7.24% vs. 4.52%, and the increased cancer mortality was MLH1: 5.74% vs. 2.55% and MSH6: 5.22% vs. 2.97%. Here, MLH1 is linked to cancer.